Self-injection Devices Market Size, Share & Trends Report

Self-injection Devices Market Size, Share & Trends Analysis By Product (Auto Injectors, Pen Injectors), By Usability (Disposable, Reusable), By Application (Cancer, Autoimmune Disorders, Hormonal Disorders), By Region, And Segment Forecasts, 2025 - 2030

Report ID: GVR-4-68039-919-4
Number of Report Pages: 120
Format: PDF, Horizon Databook

Historical Range: 2018 - 2023
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Self-injection Devices by Product Outlook (Revenue, USD Million, 2018 - 2030)
- Needle-free injectors
- Autoinjectors
- Pen injectors
- Wearable injectors
Self-injection Devices by Usability Outlook (Revenue, USD Million, 2018 - 2030)
- Disposable
- Reusable
Self-injection Devices by Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer
- Autoimmune disorders
- Hormonal disorders
- Pain management
- Others
Self-injection Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Self-injection Devices Market, By Product
    - Needle-free injectors
    - Autoinjectors
    - Pen injectors
    - Wearable injectors
  - North America Self-injection Devices Market, By Usability
    - Disposable
    - Reusable
  - North America Self-injection Devices Market, By Application
    - Cancer
    - Autoimmune disorders
    - Hormonal disorders
    - Pain management
    - Others
  - U.S.
    - U.S. Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - U.S. Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - U.S. Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Canada
    - Canada Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Canada Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Canada Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Mexico
    - Mexico Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Mexico Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Mexico Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
- Europe
  - Europe Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Needle-free injectors
    - Autoinjectors
    - Pen injectors
    - Wearable injectors
  - Europe Usability Outlook (Revenue in USD Million, 2018 - 2030)
    - Disposable
    - Reusable
  - Europe Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Cancer
    - Autoimmune disorders
    - Hormonal disorders
    - Pain management
    - Others
  - UK
    - UK Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - UK Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - UK Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - France
    - France Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - France Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - France Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Italy
    - Italy Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Italy Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Italy Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Spain
    - Spain Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Spain Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Spain Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Denmark
    - Denmark Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Denmark Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Denmark Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Sweden
    - Sweden Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Sweden Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Sweden Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Norway
    - Norway Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Norway Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Norway Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
- Asia Pacific
  - Asia Pacific Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Needle-free injectors
    - Autoinjectors
    - Pen injectors
    - Wearable injectors
  - Asia Pacific Usability Outlook (Revenue in USD Million, 2018 - 2030)
    - Disposable
    - Reusable
  - Asia Pacific Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Cancer
    - Autoimmune disorders
    - Hormonal disorders
    - Pain management
    - Others
  - Japan
    - Japan Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Japan Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Japan Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - China
    - China Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - China Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - China Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - India
    - India Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - India Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - India Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Australia
    - Australia Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Australia Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Australia Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - South Korea
    - South Korea Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - South Korea Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - South Korea Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Thailand
    - Thailand Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Thailand Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Thailand Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
- Latin America
  - Latin America Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Needle-free injectors
    - Autoinjectors
    - Pen injectors
    - Wearable injectors
  - Latin America Usability Outlook (Revenue in USD Million, 2018 - 2030)
    - Disposable
    - Reusable
  - Latin America Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Cancer
    - Autoimmune disorders
    - Hormonal disorders
    - Pain management
    - Others
  - Brazil
    - Brazil Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Brazil Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Brazil Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Argentina
    - Argentina Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Argentina Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Argentina Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
- Middle East & Africa
  - Middle East & Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
    - Needle-free injectors
    - Autoinjectors
    - Pen injectors
    - Wearable injectors
  - Middle East & Africa Usability Outlook (Revenue in USD Million, 2018 - 2030)
    - Disposable
    - Reusable
  - Middle East & Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
    - Cancer
    - Autoimmune disorders
    - Hormonal disorders
    - Pain management
    - Others
  - South Africa
    - South Africa Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - South Africa Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - South Africa Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Saudi Arabia
    - Saudi Arabia Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Saudi Arabia Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Saudi Arabia Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - UAE
    - UAE Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - UAE Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - UAE Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others
  - Kuwait
    - Kuwait Product Outlook (Revenue in USD Million, 2018 - 2030)
      - Needle-free injectors
      - Autoinjectors
      - Pen injectors
      - Wearable injectors
    - Kuwait Usability Outlook (Revenue in USD Million, 2018 - 2030)
      - Disposable
      - Reusable
    - Kuwait Application Outlook (Revenue in USD Million, 2018 - 2030)
      - Cancer
      - Autoimmune disorders
      - Hormonal disorders
      - Pain management
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.